Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-06 4:50 pm Purchase |
2022-09-02 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 829,858 11.010% |
5,333 (+0.65%) |
Filing History |
| 2022-09-06 4:30 pm Purchase |
2022-08-24 | 13G | Cogent Biosciences, Inc. COGT |
RA Capital Management, L.P. | 3,612,207 5.490% |
3,612,207 (New Position) |
Filing History |
| 2022-09-02 4:30 pm Purchase |
2022-08-31 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,040,309 18.880% |
11,125 (+0.12%) |
Filing History |
| 2022-08-29 5:01 pm Purchase |
2022-08-25 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 9,003,018 9.900% |
147,000 (+1.66%) |
Filing History |
| 2022-08-26 4:38 pm Purchase |
2022-08-16 | 13G | Fulcrum Therapeutics, Inc. FULC |
RA Capital Management, L.P. | 7,000,000 13.450% |
7,000,000 (New Position) |
Filing History |
| 2022-08-15 5:19 pm Sale |
2022-08-15 | 13G | scPharmaceuticals Inc. SCPH |
RA Capital Management, L.P. | 0 0.000% |
-2,691,770 (Position Closed) |
Filing History |
| 2022-08-15 5:15 pm Sale |
2022-08-15 | 13G | MacroGenics, Inc. MGNX |
RA Capital Management, L.P. | 0 0.000% |
-6,103,594 (Position Closed) |
Filing History |
| 2022-08-15 5:12 pm Sale |
2022-08-15 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 0 0.000% |
-1,930,322 (Position Closed) |
Filing History |
| 2022-08-15 5:10 pm Sale |
2022-08-15 | 13G | TScan Therapeutics, Inc. TCRX |
RA Capital Management, L.P. | 0 0.000% |
-1,255,317 (Position Closed) |
Filing History |
| 2022-08-15 5:06 pm Sale |
2022-08-15 | 13G | CYTEIR THERAPEUTICS INC CYTT |
RA Capital Management, L.P. | 0 0.000% |
-3,350,506 (Position Closed) |
Filing History |
| 2022-08-15 5:04 pm Sale |
2022-08-15 | 13G | Akouos, Inc. AKUS |
RA Capital Management, L.P. | 0 0.000% |
-2,281,249 (Position Closed) |
Filing History |
| 2022-08-15 4:59 pm Sale |
2022-08-15 | 13G | Edgewise Therapeutics, Inc. EWTX |
RA Capital Management, L.P. | 0 0.000% |
-2,613,623 (Position Closed) |
Filing History |
| 2022-08-12 4:32 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 4,304,447 14.570% |
12,566 (+0.29%) |
Filing History |
| 2022-07-06 5:25 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 7,806,169 19.900% |
2,840,400 (+57.20%) |
Filing History |
| 2022-06-23 4:49 pm Unchanged |
2022-06-16 | 13D | PepGen Inc. PEPG |
RA Capital Management, L.P. | 8,131,952 34.410% |
0 (Unchanged) |
Filing History |
| 2022-06-22 4:31 pm Purchase |
2022-06-16 | 13G | Instil Bio, Inc. TIL |
RA Capital Management, L.P. | 383,540 5.930% |
383,540 (New Position) |
Filing History |
| 2022-06-21 4:35 pm Purchase |
2009-02-28 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 17,269,811 19.990% |
9,441,354 (+120.60%) |
Filing History |
| 2022-06-03 5:11 pm Sale |
2022-06-02 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 136,515 4.700% |
-111,277 (-44.91%) |
Filing History |
| 2022-05-31 5:31 pm Sale |
2022-05-26 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 247,792 8.530% |
-74,020 (-23.00%) |
Filing History |
| 2022-05-25 5:12 pm Sale |
2022-05-23 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 321,812 11.080% |
-114,773 (-26.29%) |
Filing History |